| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2000-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f09f020fc23d50c2a0dd281b5809505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8dd48b9b7825a37a10f29f35730637f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41cc4cf1e86fc6fe4ea964ffd11acf6a |
| publicationDate |
2002-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1188440-A1 |
| titleOfInvention |
Medicinal composition for oral administration |
| abstract |
The present invention is to provide a stabilizednpharmaceutical composition for oral use containing 1-ethylnmethylestern4-[[3-[p-(carboxyamidino)phenyl]-2-oxo-5-oxazolidinyl]methnyl]-1-piperazineacetate or a pharmaceutically acceptable saltnthereof having an antagonistic action to GPIIb/IIIa receptornand an oily base. The present invention is to further providena method for the manufacture of a stabilized pharmaceuticalncomposition for oral use by compounding 1-ethyl methylestern4-[[3-[p-(carboxyamidino)phenyl]-2-oxo-5-oxazolidinyl]methnyl]-1-piperazineacetate or a pharmaceutically acceptable saltnthereof with an oily base. The present invention is tonfurthermore provide a method for the stabilization of anpharmaceutical composition by compounding 1-ethyl methylestern4-[[3-[p-(carboxyamidino)phenyl]-2-oxo-5-oxazolidinyl]-metnhyl]-1-piperazineacetate or a pharmaceutically acceptable saltnthereof with an oily base. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152342-A1 |
| priorityDate |
1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |